M.  von Lilienfeld-Toal von Lilienfeld-Toal

Prof. Dr. M. von Lilienfeld-Toal von Lilienfeld-Toal


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ATAysun Tekbas
Aysun Tekbas
SBS. Bremer-Streck
S. Bremer-Streck
DWDirk K. Wissenbach
Dirk K. Wissenbach
FPF. T. Peters
F. T. Peters
MLM. von Lilienfeld-Toal von Lilienfeld-Toal
M. von Lilienfeld-Toal von Lilienfeld-Toal
Uta DahmenUta Dahmen
Uta Dahmen
Thymoquinone (TQ) is the primary component of Nigella sativa L. (NS) oil, which is renowned for its potent hepatoprotective effects attributed to its antioxidant, anti-fibrotic, anti-inflammatory, anti-carcinogenic, and both anti- and pro-apoptotic properties. The aim of this work was to establish a method of measuring TQ in serum in order to investigate the pharmacokinetics of TQ prior to a targeted therapeutic application. In the first step, a gas chromatography–mass spectrometry method for the detection and quantification of TQ in an oily matrix was established and validated according to European Medicines Agency (EMA) criteria. For the assessment of the clinical application, TQ concentrations in 19 oil preparations were determined. Second, two serum samples were spiked with TQ to determine the TQ concentration after deproteinization using toluene. Third, one healthy volunteer ingested 1 g and another one 3 g of a highly concentrated NS oil 30 and 60 min prior to blood sampling for the determination of serum TQ level. After the successful establishment and validation of the measurement method, the highest concentration of TQ (36.56 g/L) was found for a bottled NS oil product (No. 1). Since a capsule is more suitable for oral administration, the product with the third highest TQ concentration (No. 3: 24.39 g/L) was used for all further tests. In the serum samples spiked with TQ, the TQ concentration was reliably detectable in a range between 5 and 10 µg/mL. After oral intake of NS oil (No. 3), however, TQ and/or its derivatives were not detectable in human serum. This discrepancy in detecting TQ after spiking serum or following oral ingestion may be attributed to the instability of TQ in biomatrices as well as its strong protein binding properties. A pharmacokinetics study was therefore not viable. Studies on isotopically labeled TQ in an animal model are necessary to study the pharmacokinetics of TQ using alternative modalities.

30 May 2026 in BMC Public Health
Verified
Journal Article
Open access
MRMaria Madeleine Rüthrich
Maria Madeleine Rüthrich
LALeonie Ascone
Leonie Ascone
JHJakob Hammersen
Jakob Hammersen
IHInken Hilgendorf
Inken Hilgendorf
JKJana Kalkreuth
Jana Kalkreuth
MLM. von Lilienfeld-Toal von Lilienfeld-Toal
M. von Lilienfeld-Toal von Lilienfeld-Toal
Background: Upper respiratory tract infections (URTIs) are shaped by sex and gender, with stress potentially playing a critical role. However, the interplay remains poorly understood. This study examined whether women experience higher stress than men, contributing to increased URTI susceptibility and symptom burden. Methods: Our monocentric, prospective study included 273 healthy individuals (cohort H) and 194 stem-cell recipients (cohort P), enrolled between 11/2013 and 05/2017. Participants were aged ≥ 18 years. Data included demographics, household composition, smoking behavior, cancer-related characteristics, URTI-symptoms, and perceived stress (measured via 4-item perceived stress scale, PSS-4). Participants were categorized by biological sex, assuming alignment with gender. Results: In cohort H (50% women, mostly ≤ 30 years), women reported more moderate/severe URTI-symptoms than men (57% vs. 36%, p < 0.001, φ = 0.210) and higher PSS-4 scores [t(271) = 2.84, p < 0.001, d = 0.636]. In women, stress modestly correlated with symptom burden ( r = 0.15, p = 0.04). Sex and age were significant predictors of stress. In cohort P (40.5% women, mostly ≥ 30 years), men reported more URTI symptoms (83% vs. 68%, p = 0.021), while PSS-4 did not differ by sex. Stress correlated with symptom burden ( r = 0.293, p < 0.001), particularly in women ( r = 0.385, p < 0.001). Symptom burden was the only independent predictor of stress. Conclusion: The relationship between sex, stress, and URTI burden varies by health status. Healthy women, especially younger adults, experience higher stress and more severe symptoms, though stress only modestly relates to symptom burden. In immunocompromised patients, stress strongly reflects symptom severity, particularly in women, with minimal sex differences in stress. These findings highlight a complex interplay between sex, psychosocial stress, and infection outcomes, emphasizing the need for interventions addressing both biological and psychosocial determinants, particularly in vulnerable populations. Trial registration: Registry: the German Clinical Trials Register Clinical Trial Number: DRKS00005367 Registration date: 10/17/2013

19 May 2025 in Die Onkologie
Verified
Journal Article
Closed access
PDF file
ABAnnamaria Brioli
Annamaria Brioli
MLM. von Lilienfeld-Toal von Lilienfeld-Toal
M. von Lilienfeld-Toal von Lilienfeld-Toal